Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prulifloxacin versus levofloxacin for acute bacterial rhinosinusitis
2006-001837-16Phase 3Completed
- Sponsor
- Angelini Pharma
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of prulifloxacin and levofloxacin in Acute bacterial rhinosinusitis (ABRS) (2 arms), sponsored by Angelini Pharma. Primary endpoint: Clinical efficacy at test of cure. Started Jun 2006; status: completed.
02
Drugs
prulifloxacinlevofloxacin
03
Conditions
Acute bacterial rhinosinusitis (ABRS)
Beyond the preview
Go deeper on 2006-001837-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001837-16.